About Me
Growing up in a working-class family with parents struggling with significant medical conditions and a brother with an intellectual disability, I saw firsthand the struggles of everyday life and the challenges people face living with illness and limited resources. The mental health challenges of both my immediate and extended family members and my own lived experiences inspired my long-standing interest in the inner workings of the mind and brain. This led me to pursue clinical social work and ultimately psychiatry—a path that I felt would allow me to use my passion for knowledge, empathy, and life experiences to help others.
I am a clinical assistant professor of psychiatry at NYU Grossman School of Medicine, and I am also the attending psychiatrist at the NYU Langone World Trade Center Health Program, where I provide trauma-informed care to patients affected by the 9/11 terrorist attacks. In addition to this role, I am also a clinician-researcher at the NYU Langone Center for Psychedelic Medicine, where I work on clinical trials exploring novel psychedelic therapies for a variety of conditions such as depressive disorders, posttraumatic stress disorder, substance use disorders, and cancer-related distress, and I am highly active in the training and supervision of therapists learning psychedelic therapy.
My approach to patient care is rooted in a desire to truly understand each person’s unique history and suffering, combining research-based knowledge with a strong background in psychotherapy to offer tailored treatment for every individual.
Credentials
Positions
- Clinical Assistant Professor, Department of Psychiatry at NYU Grossman School of Medicine
Board Certifications
- American Board of Psychiatry & Neurology - Psychiatry, 2022
Education and Training
- Residency, NYU Grossman School of Medicine, Psychiatry, 2022
- Fellowship, Psychoanalytic Association of New York (PANY), Psychoanalytic, 2021
- MD from Michigan State University, 2018
Is this your profile?
Edit profileInsurance Plans Accepted
Please call the office for information about accepted insurance plans.
Daniel E. Roberts, MD does not accept insurance.
Clinical Trials and Research Studies
-
A Phase 2b Randomized Double-blind Placebo-controlled Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer
-
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
-
A Phase 3 Randomized Double-Blind Multicenter Study to Evaluate the Efficacy Safety and Tolerability of Psilocybin in Adults with Major Depressive Disorder
Publications
-
Yaden, Mary E.; Ching, Terence H.W.; Goldway, Noam; Roberts, Daniel E.; Hokanson, Jamila; Gukasyan, Natalie; Pittenger, Christopher; Kelmendi, Benjamin; Ross, Stephen; Glick, Gianni; O"™Donnell, Kelley C.
International review of psychiatry (Abingdon, UK). 2024 Jan 01; ?-?
-
Psychedelic medicine in psychiatry residency training: a survey of psychiatric residency program directors
Yaden, Mary E.; Ching, Terence H. W.; Goldway, Noam; Roberts, Daniel E.; Hokanson, Jamila; Gukasyan, Natalie; Pittenger, Christopher; Kelmendi, Benjamin; Ross, Stephen; Glick, Gianni; O\Donnell, Kelley C.International review of psychiatry (Abingdon, UK). 2024;
-
Zeifman, Richard J; Kettner, Hannes; Pagni, Broc A; Mallard, Austin; Roberts, Daniel E; Erritzoe, David; Ross, Stephen; Carhart-Harris, Robin L
Scientific reports. 2023 Aug 22; 13(1):13645